About this trial
This project aims to elucidate the important protective elements of social relationships and identify concrete, modifiable behavioral factors that contribute to biological and phenotypic aging in hematopoietic cell transplantation (HCT) survivors and can be used to develop biologically informed interventions to improve quality of life and prolong the healthspan of individuals with accelerated aging.
Eligibility criteria
Qualifiers
Aged 18 years and older who are competent to give their informed consent.
Ability to read, speak, and understand English.
Received a hematopoietic cell transplant within the previous 100 days.
Disqualifiers
Less then Aged 18 years and older who are competent to give their informed consent.
Cannot read, speak, and understand English.
Has not received a hematopoietic cell transplant within the previous 100 days.
Trial design
Treatments tested in this trial
- Biospecimen Collection
- Electronic Health Record Review
- Questionnaire Administration
Treatment groups
Sponsors and collaborators
Medical College of Wisconsin
Lead sponsor
National Institute on Aging (NIA)
Collaborator